Venture • Life Science

Sun Mountain Capital Invests In Exagen

On February 25, 2011, private equity firm Sun Mountain Capital invested in life science company Exagen

Investment Context
  • This is Sun Mountain Capital’s 1st transaction in the Life Science sector.
  • This is Sun Mountain Capital’s 7th transaction in the United States.
  • This is Sun Mountain Capital’s 1st transaction in California.
Investment Fate
  • Exagen went public in 2019.

Explore All 557 Venture Life Science Deals - Search the Database Free


Investment Summary

Date February 25, 2011
Target Exagen
Sector Life Science
Investor(s) Sun Mountain Capital
Deal Type Venture

Target Company

Exagen

Vista, California, United States
Exagen is a patient-focused, discovery-driven, CLIA-certified, CAP-accredited laboratory focused on providing physicians with products that address the significant unmet need for accurate and timely diagnosis, prognosis and monitoring of ARD/CTD. Exagen was founded in 2002 and is based in Vista, California.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

Sun Mountain Capital

Santa Fe, New Mexico, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2006
Size Small
Type Sector Agnostic
DESCRIPTION

Sun Mountain Capital is a provider of fund investment advisory services as well as a direct investor. Sun Mountain's advisory practice develops customized private equity programs for institutional investors while the Firm's direct investment program looks to commit $250k to $10 million of capital for a variety of situations. Sun Mountain looks to be an active/hands-on investor. Sun Mountain Capital was formed in 2006 and is based in Santa Fe, New Mexico.


Deal Context for Investor #
Overall 7 of 15
Sector: Life Science 1 of 2
Type: Venture 7 of 14
State: California 1 of 3
Country: United States 7 of 15
Year: 2011 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-08-30 Skorpios Technologies

Albuquerque, New Mexico, United States

Skorpios Technologies is a fabless semiconductor company delivering highly integrated communications products based upon our proprietary, wafer-scale, silicon photonics process. Skorpios Technologies was founded in 2009 and is based in Albuquerque, New Mexico.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-06-27 Teucrium

Burlington, Vermont, United States

Teucrium is an issuer of single commodity focused next generation exchange traded products in the agricultural and energy sectors. Teucrium designs investment vehicles that offer liquidity, transparency and capacity in single-commodity investing to investors and hedgers in the popular and highly liquid ETP format. Teucrium was founded in 2009 and is based in Burlington, Vermont.

Buy -